UK neonatal division wins NHS framework agreement

Summary by AI ^BETAClose X

Inspiration Healthcare Group plc has secured a renewed four-year NHS framework agreement for its respiratory care units in England and Wales, reinforcing its position as the number one neonatal ventilator supplier for the 2025/26 period. This agreement provides enhanced medium-term revenue visibility, supports ongoing capital equipment sales, consumables, and service revenue, and strengthens the company's competitive standing in the UK neonatal care market. The renewal ensures continued streamlined access for NHS Trusts to the Group's neonatal respiratory and critical care solutions.

Disclaimer*

Inspiration Healthcare Group PLC

05 March 2026

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

UK neonatal division secures renewed four-year NHS framework agreement

No. 1 position in neonatal ventilator suppliers to England & Wales NHS

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces that it has been re-appointed by the NHS supply chain as an approved supplier for its respiratory care units for newborns under a new four-year framework agreement covering England and Wales. In addition, the Company has been ranked as the number one neonatal ventilator supplier* for the 2025/26 period under the NHS framework in England and Wales.

Strategic and financial impact

· Secures framework position for four years, providing enhanced medium-term revenue visibility within the UK market

· Reinforces Inspiration Healthcare's market-leading position in neonatal ventilation across England and Wales

· Supports ongoing capital equipment sales, associated consumables and service revenue streams

· Strengthens competitive positioning in future procurement cycle

The renewed framework appointment ensures continued streamlined access for NHS Trusts to Inspiration Healthcare's portfolio of neonatal respiratory and critical care solutions for vulnerable patients. Framework inclusion supports procurement efficiency, regulatory compliance and value-based purchasing across the healthcare system, enabling NHS Trusts to obtain equipment through a compliant and pre-approved route. The four-year term provides enhanced visibility of opportunity within the NHS procurement cycle and strengthens the Company's strategic positioning in the UK neonatal care market.

Raffi Stepanian, CEO of Inspiration Healthcare, said: "The renewal of this framework and our ranking within the NHS reflects our continued commitment to medical excellence, innovation and the advancement of clinical outcomes within neonatal intensive care environments. Our neonatal ventilator systems are designed to deliver precise, reliable respiratory support for premature and critically ill newborns, and we are consistently investing in product development, clinical training and service support to ensure that clinicians are equipped to support safe and effective care for vulnerable patients. We remain focused on converting this strategic positioning into further market share gains and long-term shareholder value."

*The number one ranking reflects the Company's leading market share position within the NHS supply chain neonatal ventilator category for the designated period.

For further information, please contact:

Inspiration Healthcare Group plc		Tel: +44 (0)330 175 0000
Raffi Stepanian, Chief Executive Officer
Alan Olby, Chief Financial Officer

Panmure Liberum (Nominated Adviser & Broker)				Tel: +44 (0)20 3100 2000
Will Goode
Emma Earl
Mark Rogers

Cavendish Capital Markets (Joint Broker)			Tel: + 44 (0)20 7220 0500
Giles Balleny / Joe Smith
Nigel Birks
Harriet Ward

Walbrook PR Ltd (Media & IR)	Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
Anna Dunphy		Mob: +44 (0) 7876 741 001
Rachel Broad		Mob: +44 (0) 7747 515 393

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END